Appendicectomy as Disease-Modifying Therapy for Ulcerative Colitis
Key Highlights
Medicine · Gastroenterology
The COSTA study provides evidence that appendicectomy combined with advanced therapy leads to higher 12-month clinical remission rates than switching to a JAK inhibitor in patients with moderate-to-severe, biologic-exposed ulcerative colitis. Researchers demonstrated that this surgical approach may serve as a disease-modifying treatment for a condition typically managed with escalating pharmacotherapy. For you as a medical student focused on clinically relevant research, this study represents a paradigm-shifting intervention that could directly alter treatment algorithms and improve patient outcomes in a common clinical scenario.
Novelty: 88%
Rigor: 80%
Significance: 92%
Validity: 78%
Clarity: 85%
Update Your Briefing Preferences
Stay curious. Stay informed —
Science Briefing
Your briefing is personalized based on your selected fields, keywords, and research interests.
